Zobrazeno 1 - 10
of 218
pro vyhledávání: '"Dutch Childhood Oncology Group"'
Autor:
Veerman AJ (AUTHOR), Kamps WA (AUTHOR), van den Berg H (AUTHOR), van den Berg E (AUTHOR), Bökkerink JP (AUTHOR), Bruin MC (AUTHOR), van den Heuvel-Eibrink MM (AUTHOR), Korbijn CM (AUTHOR), Korthof ET (AUTHOR), van der Pal K (AUTHOR), Stijnen T (AUTHOR), van Weel Sipman MH (AUTHOR), van Weerden JF (AUTHOR), van Wering ER (AUTHOR), van der Does-van den Berg A (AUTHOR), Dutch Childhood Oncology Group (CORPORATE AUTHOR)
Publikováno v:
Lancet Oncology. Oct2009, Vol. 10 Issue 10, p957-966. 10p.
Autor:
Stutterheim J; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. j.stutterheim@prinsesmaximacentrum.nl., van der Waarden R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Groot-Kruseman HA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands., Sonneveld E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands., de Haas V; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands., Dandis R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Schoot CE; Department of Experimental Immunohematology, Sanquin Research and Landsteiner Laboratory Amsterdam, Amsterdam University Medical Center, Amsterdam, The Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands.
Publikováno v:
Leukemia [Leukemia] 2024 Nov; Vol. 38 (11), pp. 2376-2381. Date of Electronic Publication: 2024 Sep 10.
Autor:
van der Ham CG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Suurenbroek LC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kleisman MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Antić Ž; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Lelieveld SH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Yeong M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Westera L; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group, Utrecht, The Netherlands., Sonneveld E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group, Utrecht, The Netherlands., Hoogerbrugge PM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group, Utrecht, The Netherlands., van der Velden VHJ; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., van Leeuwen FN; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. r.kuiper@prinsesmaximacentrum.nl.; Department of Genetics, Utrecht University Medical Center, Utrecht University, Utrecht, The Netherlands. r.kuiper@prinsesmaximacentrum.nl.
Publikováno v:
Leukemia [Leukemia] 2024 Nov; Vol. 38 (11), pp. 2366-2375. Date of Electronic Publication: 2024 Sep 04.
Autor:
Bouwman E; Radboud University Medical Center, Nijmegen, The Netherlands., Penson A; Radboud University Medical Center, Nijmegen, The Netherlands., de Valk M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Oever SR; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Pal HJH; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; PanCare, Bussum, The Netherlands., van Dulmen-den Broeder E; Amsterdam University Medical Center, Amsterdam, The Netherlands., Blijlevens NMA; Radboud University Medical Center, Nijmegen, The Netherlands., Bresters D; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Feijen EAM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van den Heuvel-Eibrink MM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Erasmus Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.; Utrecht University and Utrecht Medical Center, Utrecht, The Netherlands., van der Heiden-van der Loo M; Dutch Childhood Oncology Group-Late Effects After Childhood Cancer (LATER) Registry, Utrecht, The Netherlands., Michel G; Faculty of Health Sciences and Medicine, University of Lucerne, Lucerne, Switzerland., Ronckers CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Division of Childhood Cancer Epidemiology, Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Teepen JC; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; University Medical Center Groningen, Groningen, The Netherlands., Versluys BAB; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kremer LCM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Utrecht University and Utrecht Medical Center, Utrecht, The Netherlands.; Amsterdam University Medical Center, Amsterdam, The Netherlands., Pluijm SMF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Loonen JJ; Radboud University Medical Center, Nijmegen, The Netherlands.
Publikováno v:
Cancer [Cancer] 2024 Aug 15; Vol. 130 (16), pp. 2856-2872. Date of Electronic Publication: 2024 Apr 25.
Autor:
Østergaard A; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Mathematical Institute, Leiden University, Leiden, The Netherlands.; Department of Biomedical Science, Section Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands., de Groot-Kruseman H; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands., Moorman AV; Leukaemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University, Newcastle upon Tyne, UK.; United Kingdom Acute Lymphoblastic Leukaemia (UKALL) study group, Liverpool, UK., Vora A; United Kingdom Acute Lymphoblastic Leukaemia (UKALL) study group, Liverpool, UK.; Department of Haematology, Great Ormond Street Hospital, London, UK., Zimmermann M; Department of Paediatric Haematology and Oncology, Hannover Medical School, 30625, Hannover, Germany.; Berlin-Frankfurt-Münster Study Group (BFM), Frankfurt, Germany., Schrappe M; Berlin-Frankfurt-Münster Study Group (BFM), Frankfurt, Germany.; Department of Paediatrics, University Medical Centre Schleswig-Holstein, Kiel, Germany., Biondi A; Department of Pediatrics, University of Milano-Bicocca, Monza, Italy.; Associazione Italiana di Ematologia e Oncologia Pediatrica (AIEOP), Bologna, Italy., Escherich G; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; Childhood Acute Lymphoblastic Leukemia study group (CoALL), Hamburg, Germany., Stary J; Department of Pediatric Hematology and Oncology, Second Faculty of Medicine, Charles University, Prague, Czech Republic., Imai C; Department of Pediatrics, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Japan.; Children's Cancer and Leukemia Study Group (CCLSG), Nagoya, Japan., Imamura T; Department of Pediatrics, Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Kyoto, Japan.; Japan Childhood Leukemia Study Group (JACLS), Nagoya, Japan., Heyman M; Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.; Department of Paediatric Oncology, Karolinska University Hospital, Stockholm, Sweden.; Nordic Society of Paediatric Haematology and Oncology (NOPHO), Nordic Countries, Uppsala, Sweden., Schmiegelow K; Department of Pediatrics and Adolescent Medicine, University Hospital Rigshospitalet, Institute of Clinical Medicine, Faculty of Medicine, University of Copenhagen, Copenhagen, Denmark.; Nordic Society of Paediatric Haematology and Oncology (NOPHO), Nordic and Baltic Countries, Uppsala, Sweden., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands. r.pieters@prinsesmaximacentrum.nl.; Dutch Childhood Oncology Group (DCOG), Utrecht, The Netherlands. r.pieters@prinsesmaximacentrum.nl.
Publikováno v:
Leukemia [Leukemia] 2024 Jul; Vol. 38 (7), pp. 1477-1487. Date of Electronic Publication: 2024 Jun 06.
Autor:
van Weelderen RE; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands., Harrison CJ; Leukemia Research Cytogenetics Group, Translational and Clinical Research Institute, Newcastle University Centre for Cancer, Newcastle-upon-Tyne, United Kingdom., Klein K; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.; Department of Pediatrics, Wilhelmina Children's Hospital/University Medical Center Utrecht, Utrecht, The Netherlands., Jiang Y; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Abrahamsson J; Department of Pediatrics, Institute of Clinical Sciences, Salgrenska University Hospital, Gothenburg, Sweden., Alonzo T; Division of Biostatistics, University of Southern California, Los Angeles, CA., Aplenc R; Division of Oncology, Children's Hospital of Philadelphia, Philadelphia, PA., Arad-Cohen N; Department of Pediatric Hematology-Oncology, Ruth Rappaport Children's Hospital, Rambam Health Care Campus, Haifa, Israel., Bart-Delabesse E; Institut Universitaire du Cancer Toulouse-Oncopole, Laboratoire d'Hématologie secteur Génétique des Hémopathies, Toulouse, France., Buldini B; Division of Pediatric Hematology, Oncology, and Stem Cell Transplant, Department of Maternal and Child Health, Padua University, Padua, Italy., De Moerloose B; Department of Pediatric Hematology-Oncology and Stem Cell Transplantation, Ghent University Hospital, Ghent, Belgium., Dworzak MN; Department of Pediatrics, St. Anna Children's Hospital, Medical University of Vienna & St. Anna Children's Cancer Research Institute, Vienna, Austria., Elitzur S; Department of Pediatric Hematology and Oncology, Schneider Children's Medical Center & Tel Aviv University, Tel Aviv, Israel., Fernández Navarro JM; Department of Pediatric Oncohematology, Hospital Universitari i Politècnic la Fe, Valencia, Spain., Gamis A; Department of Hematology and Oncology, Children's Mercy Hospital, Kansas City, MO., Gerbing RB; Department of Statistics, Children's Oncology Group, Monrovia, CA., Goemans BF; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., de Groot-Kruseman HA; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; DCOG, Dutch Childhood Oncology Group, Utrecht, The Netherlands., Guest E; Department of Hematology and Oncology, Children's Mercy Hospital, Kansas City, MO., Ha SY; Department of Pediatrics & Adolescent Medicine, Hong Kong Children's Hospital, Kowloon Bay, Hong Kong., Hasle H; Department of Pediatrics and Adolescent Medicine, Aarhus University Hospital, Aarhus, Denmark., Kelaidi C; Department of Pediatric Hematology and Oncology, Aghia Sophia Children's Hospital, Athens, Greece., Lapillonne H; Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Paris, France., Leverger G; Department of Pediatric Hematology and Oncology, Hôpital Armand Trousseau, Paris, France., Locatelli F; Department of Pediatric Hematology and Oncology and Cell and Gene Therapy, IRCCS Ospedale Pediatrico Bambino Gesù, Catholic University of the Sacred Heart, Rome, Italy., Miyamura T; Department of Pediatrics, Osaka University Graduate School of Medicine, Suita, Japan., Norén-Nyström U; Department of Clinical Sciences, Pediatrics, Umeå University, Umeå, Sweden., Polychronopoulou S; Department of Pediatric Hematology and Oncology, Aghia Sophia Children's Hospital, Athens, Greece., Rasche M; Department of Pediatric Hematology and Oncology, University Hospital Essen, Essen, Germany., Rubnitz JE; Department of Oncology, St. Jude Children's Research Hospital, Memphis, TN., Stary J; Department of Pediatric Hematology and Oncology, University Hospital Motol and Second Faculty of Medicine, Charles University, Prague, Czech Republic., Tierens A; Department of Pathobiology and Laboratory Medicine, University Health Network, Toronto General Hospital, Toronto, ON, Canada., Tomizawa D; Children's Cancer Center, National Center for Child Health and Development, Tokyo, Japan., Zwaan CM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology, Erasmus Medical Center Sophia Children's Hospital, Rotterdam, The Netherlands., Kaspers GJL; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Emma Children's Hospital, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Publikováno v:
Blood advances [Blood Adv] 2024 Jun 25; Vol. 8 (12), pp. 3200-3213.
Autor:
van der Sluis IM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Brigitha LJ; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Pediatric Oncology and Hematology, Erasmus MC-Sophia Children's Hospital, Rotterdam, the Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Biomedical Data Sciences, Medical Statistics, Leiden University Medical Center, Leiden, the Netherlands.; Mathematical Institute, Leiden University, the Netherlands., de Groot-Kruseman HA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Bierings M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van den Bos C; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Haas V; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands., Hoogerbrugge PM; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Tissing WJE; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Veening MA; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group, Utrecht, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 May 10; Vol. 42 (14), pp. 1676-1686. Date of Electronic Publication: 2024 Feb 02.
Autor:
van Outersterp I; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., van der Velden VHJ; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands., Hoogeveen PG; Department of Immunology, Laboratory Medical Immunology, Erasmus MC, University Medical Center Rotterdam, The Netherlands., Vaitkevičienė GE; Faculty of Medicine, Vilnius University, Lithuania.; Center for Pediatric Oncology and Hematology, Vilnius University Hospital Santaros Klinikos, Lithuania., Sonneveld E; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Dutch Childhood Oncology Group, Utrecht, The Netherlands., van Haaften G; Department of Genetics, University Medical Center Utrecht, The Netherlands., Kuiper RP; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Genetics, University Medical Center Utrecht, The Netherlands., Zur Stadt U; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Germany., Escherich G; Department of Pediatric Hematology and Oncology, University Medical Center Hamburg Eppendorf, Germany., Boer JM; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., den Boer ML; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Pediatric Oncology and Hematology, Erasmus MC - Sophia Children's Hospital, Rotterdam, The Netherlands.
Publikováno v:
HemaSphere [Hemasphere] 2023 Sep 19; Vol. 7 (10), pp. e967. Date of Electronic Publication: 2023 Sep 19 (Print Publication: 2023).
Autor:
Matarraz S; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. smats@usal.es.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain. smats@usal.es., Leoz P; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Yeguas-Bermejo A; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., van der Velden V; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Bras AE; Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands., Sánchez Gallego JI; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Lecrevisse Q; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Ayala-Bueno R; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Teodosio C; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Criado I; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., González-González M; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain., Flores-Montero J; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Avendaño A; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Vidriales MB; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Chillón MC; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., González T; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., García-Sanz R; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Prieto Conde MI; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Hematology Department, University Hospital of Salamanca, CIBERONC (CB16/12/00233), IBSAL, Accelerator program and Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca), Salamanca, Spain., Villamor N; Hematology Service, Hospital Clinic, Barcelona, Spain., Magnano L; Hematology Service, Hospital Clinic, Barcelona, Spain., Colado E; Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Fernández P; FACS/Stem Cell Laboratory, Kantonsspital Aarau, Aarau, Switzerland., Sonneveld E; Dutch Childhood Oncology Group, The Hague, The Netherlands., Philippé J; Department of Diagnostic Sciences, Faculty of Medicine and Health Sciences, Ghent University, Ghent, Belgium., Reiterová M; CLIP-Department of Pediatric Hematology and Oncology, Second Medical Faculty, Charles University and University Hospital Motol, Prague, Czech Republic., Caballero Berrocal JC; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Diaz-Gálvez FJ; Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain., Ramos F; Department of Hematology, Complejo Asistencial Universitario de León, León, Spain., Dávila Valls J; Department of Hematology, Complejo Asistencial de Ávila, Ávila, Spain., Manjón Sánchez R; Department of Hematology, Complejo Asistencial de Zamora, Zamora, Spain., Solano Tovar J; Department of Hematology, Complejo Asistencial Universitario de Palencia, Palencia, Spain., Calvo X; Pathology Service, Hospital del Mar, Barcelona, Spain., García Alonso L; Hematology Service, University Hospital of Getafe, Madrid, Spain., Arenillas L; Pathology Service, Hospital del Mar, Barcelona, Spain., Alonso S; Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Fonseca A; Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., Quirós Caso C; Hematology Department and Laboratory Medicine Department, Hospital Universitario Central de Asturias, Oviedo, Spain., van Dongen JJM; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain.; Department of Immunology, Leiden University Medical Center, Leiden, The Netherlands., Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cáncer (IBMCC; CSIC-University of Salamanca); Cytometry Service, NUCLEUS; Department of Medicine, University of Salamanca (USAL) and Institute of Biomedical Research of Salamanca (IBSAL), Salamanca, Spain. orfao@usal.es.; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto de Salud Carlos III, 28029, Madrid, Spain. orfao@usal.es.
Publikováno v:
Blood cancer journal [Blood Cancer J] 2023 Sep 04; Vol. 13 (1), pp. 132. Date of Electronic Publication: 2023 Sep 04.
Autor:
Pieters R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands., de Groot-Kruseman H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands., Fiocco M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands.; Department of Biomedical Data Science, Section Medical Statistics, Leiden University Medical Center, Leiden, the Netherlands.; Mathematical Institute, Leiden University, Leiden, the Netherlands., Verwer F; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands., Van Overveld M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Sonneveld E; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands., van der Velden V; Department of Immunology, Erasmus MC, Rotterdam, the Netherlands., Beverloo HB; Department of Clinical Genetics, Erasmus MC, Rotterdam, the Netherlands., Bierings M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands., Dors N; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., de Haas V; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Dutch Childhood Oncology Group (DCOG), Utrecht, the Netherlands., Hoogerbrugge P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Van der Sluis I; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Tissing W; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Veening M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Boer J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Den Boer M; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2023 Sep 01; Vol. 41 (25), pp. 4130-4142. Date of Electronic Publication: 2023 Jul 17.